Reduced Genome Bacteria for Stable Gene Cloning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bacterial hosts, such as E. coli, have high mutation rates due to intrinsic mechanisms that lead to unwanted genotypic and phenotypic alterations, making it difficult to clone certain genes, especially those encoding error-prone DNA polymerases, which are essential for maintaining genetic stability in laboratory settings.
Innovation Solution
Development of reduced genome bacteria with non-functional genes encoding DNA Polymerase II, IV, and V, achieved through deletion or disruption, resulting in a genome that is 5-30% smaller than the native parent strain and lacking insertion sequences, providing a stable host for cloning difficult genes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If genes encoding error-prone DNA polymerases (Pol II, Pol IV, Pol V) are kept functional in E. coli, then the bacteria can survive in natural environments with high mutation rates beneficial for adaptation, but in laboratory settings this leads to unwanted genotypic and phenotypic alterations and genetic instability
Solution Approach 1:
The patent segments the DNA polymerase functions by selectively inactivating specific error-prone polymerase genes (polB for Pol II, dinB for Pol IV, umuDC for Pol V) while preserving other essential polymerase functions. This segmentation allows the bacteria to maintain genetic stability for cloning purposes while retaining sufficient adaptability through other DNA repair and replication mechanisms.
Solution Approach 2:
The patent extracts and removes the harmful error-prone DNA polymerase functions from the bacterial system by deleting or inactivating the specific genes encoding Pol II, Pol IV, and Pol V. This extraction eliminates the source of unwanted mutations while preserving the essential replication functions carried out by other polymerases.
2Reliability
If the bacterial genome is reduced by deleting nonessential genes to improve cloning stability, then genetic stability improves and genome size decreases, but the bacteria may lose essential functions needed for survival or protein production
Solution Approach 1:
The patent applies local quality by making specific targeted modifications to the genome (inactivating only polB, dinB, and umuDC genes) rather than broad reductions. This localized approach affects only the specific error-prone polymerase functions while preserving other genes essential for protein production and bacterial survival, thus maintaining high cloning stability without sacrificing productivity.
Solution Approach 2:
The patent changes the functional state of specific genes from active to inactive (parameter change) without altering the overall genome structure or other essential functions. By changing the activity parameter of only the error-prone polymerase genes while maintaining all other parameters normal, the bacteria achieve improved cloning stability while retaining full protein production capability.
3Reliability
If multiple genes are deleted to create a reduced genome strain, then the genome becomes smaller and more stable, but the complexity of strain development and characterization increases
Solution Approach 1:
The patent employs asymmetric gene inactivation strategies where different combinations of polymerase genes are targeted (single, double, or triple deletions) depending on the specific application requirements. This asymmetric approach allows flexible optimization of stability versus complexity trade-offs, enabling users to choose the appropriate level of gene deletion based on their specific cloning needs.
Solution Approach 2:
The patent performs preliminary identification and selection of target genes (polB, dinB, umuDC) based on their known error-prone characteristics before conducting the actual deletion experiments. This preliminary action provides a clear roadmap for strain development, reducing the complexity of the overall process by pre-determining which genes should be targeted and what outcomes to expect.
4Measurement precision
If error-prone DNA polymerases are inactivated to reduce mutation rates, then nucleic acid fidelity improves, but the bacteria's ability to generate genetic diversity for survival in changing environments is reduced
Solution Approach 1:
The patent merges multiple DNA polymerase functions into a coordinated system where the error-prone polymerases (Pol II, Pol IV, Pol V) are inactivated but other replication and repair polymerases remain functional. This merging of remaining functions creates a complementary system that maintains high nucleic acid fidelity for cloning while preserving sufficient genetic adaptability through alternative DNA repair pathways and replication mechanisms.
Solution Approach 2:
The patent converts the harmful error-prone mutation activity into a benefit by selectively removing it. The error-prone polymerases, which normally cause unwanted mutations, are inactivated to provide high-fidelity cloning. However, the bacteria retain other DNA repair and replication mechanisms that can generate controlled genetic diversity when needed, thus converting the potential harm of complete polymerase inactivation into the benefit of controlled fidelity with retained adaptability.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Reduced genome bacteria with improved genetic stability are provided. Also provided are methods of producing polypeptides using the reduced genome bacteria with improved genetic stability.